Colon-specific delivery of celecoxib is a potential strategy to improve toxicological and pharmacological properties of the selective Cox-2 inhibitor: implication in treatment of familiar adenomatous polyposis-Reference-Cited by-同舟云学术

Colon-specific delivery of celecoxib is a potential strategy to improve toxicological and pharmacological properties of the selective Cox-2 inhibitor: implication in treatment of familiar adenomatous polyposis

Published:2012-05-27 Issue:6 Volume:20 Page:524-534
ISSN:1061-186X
Container-title:Journal of Drug Targeting
language:en
Short-container-title:Journal of Drug Targeting

Author:

Lee Yonghyun,Kim Hyunjeong,Kim Wooseong,Yoon Jeong-Hyun,Jeong Seong Hoon,Jung Yunjin

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

Reference22 articles.

1. Celecoxib for the Prevention of Colorectal Adenomatous Polyps

2. Why do cyclo-oxygenase-2 inhibitors cause cardiovascular events?

3. Cardiovascular Risk Associated with Celecoxib

4. Selective Inhibition of Cyclooxygenase-2 Enhances Platelet Adhesion in Hamster Arterioles In Vivo

5. Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Colon-Targeted Prodrug of Riluzole Improves Therapeutic Effectiveness and Safety upon Drug Repositioning of Riluzole to an Anti-Colitic Drug;Molecular Pharmaceutics;2022-08-31

2. Gut-Restricted Selective Cyclooxygenase-2 (COX-2) Inhibitors for Chemoprevention of Colorectal Cancer;Journal of Medicinal Chemistry;2021-07-19

3. Preparation and Evaluation of Amino Acid Conjugates of Celecoxib as Prodrugs to Improve the Pharmacokinetic and Therapeutic Properties of Celecoxib;Pharmaceutics;2020-10-30

4. Colon-Targeted Delivery Facilitates the Therapeutic Switching of Sofalcone, a Gastroprotective Agent, to an Anticolitic Drug via Nrf2 Activation;Molecular Pharmaceutics;2019-08-06

5. Celecoxib in Cancer Therapy and Prevention – Review;Current Drug Targets;2019-01-25